Business
C4 Therapeutics’ Stock Skyrockets Over 310% in 3 Months
The stock of C4 Therapeutics, (Ticker: CCCC or C4T) have surged an astounding 310.1% over the past three months, dwarfing the industry’s overall increase of...
First Wave BioPharma Witnesses Notable Stock Surge
First Wave BioPharma, a clinical stage biopharmaceutical company, is currently witnessing a substantial surge in its stock value, leaving investors and market analysts intrigued. The...
Novartis and Voyager Foge $100M Gene Therapy Deal, Stock Rises
In a groundbreaking move towards advancing gene therapy candidates for genetic disorders, Voyager Therapeutics announced on Tuesday a lucrative licensing deal with Swiss-based pharmaceutical giant...
TDCX Inc Stock Soars Over 35% Following Acquisition Offer
The stock of TDCX Inc, a leading customer experience company headquartered in Singapore, witnessed a staggering surge of more than 35% today after the company...
AST SpaceMobile Provides Fundraising Update – Stock Soars
AST SpaceMobile, the innovative company at the forefront of building the inaugural space-based cellular broadband network, accessible directly through everyday smartphones, issued an interim update...
Stocks Dip as Bond Yields Hit New Heights
In a turbulent session on Wednesday, US stocks experienced a slide, driven by a surge in bond yields and diminishing optimism regarding swift interest-rate cuts....
Stock Markets Face Downbeat Start to 2024: Major Indices Dip
In a sharp contrast to the euphoria that marked the end of 2023, the stock markets stumbled out of the gate in the new year,...
Bit Brother and Cruxforce Agreement Triggers Heavy Trading
Bit Brother announced on Tuesday that it has entered into a consulting agreement with Cruxforce, LLC, as part of its strategic initiative to secure a...
SenesTech Inc and Pesterminators Collaboration Triggers Stock Surge
SenesTech Inc, the industry leader in fertility control solutions aimed at managing animal pest populations, made a significant announcement today regarding the expansion of its...
Anavex Life Sciences Stock Tumble 38% on Rett Syndrome Trial Disappointment
Anavex Life Sciences, a clinical-stage biopharmaceutical company, experienced a significant setback on Tuesday as its stock plummeted by approximately 38% in premarket trading. This sharp...